newsfilter
← Latest News
GlobeNewswire·

Molecular Templates Announces Partial Clinical Hold for Phase 1 Study of MT-0169

AUSTIN, Texas, April 07, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")), today announced that the U.S. Food and Drug Administration (the "FDA") informed MTEM that